The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio-Reference-Cited by-同舟云学术

The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio

Published:2007-07-17 Issue:3 Volume:116 Page:268-275
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Hood Susan J.¹,Taylor Kevin P.¹,Ashby Michael J.¹,Brown Morris J.¹

Affiliation:

1. From the Clinical Pharmacology Unit, Department of Medicine, University of Cambridge (S.J.H., M.J.A., M.J.B.), and Clinical Biochemistry, Addenbrookes Hospital (K.P.T.), Cambridge, UK.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference52 articles.

1. HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION

2. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study

3. Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension

4. A Screening Test to Identify Aldosterone-Producing Adenoma by Measuring Plasma Renin Activity

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population;Journal of the Endocrine Society;2024-06-05

2. Exploratory study on the relationship between urinary sodium/potassium ratio, salt intake, and the antihypertensive effect of esaxerenone: the ENaK Study;Hypertension Research;2024-01-11

3. Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis;Journal of Human Hypertension;2024-01-11

4. Comparison of different medical treatments for primary hyperaldosteronism: a systematic review and network meta-analysis;Therapeutic Advances in Chronic Disease;2024-01

5. 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism;Endocrinology and Metabolism;2023-12-31